Monte Rosa Therapeutics
GLUE
GLUE
52 hedge funds and large institutions have $560M invested in Monte Rosa Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 7 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 53 → 52 (-1)
25% less capital invested
Capital invested by funds: $742M → $560M (-$182M)
Holders
52
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$26.9M | |
| 2 | +$16.9M | |
| 3 | +$10.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.38M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.99M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$6.13M | |
| 3 | -$3.06M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$1.95M |
| 5 |
E
Ergoteles
New York
|
-$1.52M |